Janssen Submits Application to FDA for Simeprevir (TMC435) for Combo Tx of Gen 1 (with peg +riba)
Bills said
Apr 4, 2013
Not alone at all I stopped 3rd time in January and I still reak of it. After 3 times I don't think it works for me Others make it but I didn't It's pills or nothing.
Bills
Biggyb said
Apr 3, 2013
I will never take interferon drug ever again. And i know i am not alone.
Cinnamon Girl said
Apr 3, 2013
Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
-- Filing Based on Phase 3 Data in Treatment-Naïve and Treatment-Experienced Patients with Compensated Liver Disease --
Raritan, N.J., March 28, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for simeprevir (TMC435), an investigational NS3/4A protease inhibitor, administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients.
Not alone at all I stopped 3rd time in January and I still reak of it. After 3 times I don't think it works for me Others make it but I didn't It's pills or nothing.
Bills
I will never take interferon drug ever again. And i know i am not alone.
Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
-- Filing Based on Phase 3 Data in Treatment-Naïve and Treatment-Experienced Patients with Compensated Liver Disease --
Raritan, N.J., March 28, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for simeprevir (TMC435), an investigational NS3/4A protease inhibitor, administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients.
Full aritcle...
http://www.prnewswire.com/news-releases/janssen-submits-new-drug-application-to-us-fda-for-simeprevir-tmc435-for-combination-treatment-of-adult-patients-with-genotype-1-chronic-hepatitis-c-200501671.html